Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement.
Fusaroli M, Salvo F, Begaud B, AlShammari TM, Bate A, Battini V, Brueckner A, Candore G, Carnovale C, Crisafulli S, Cutroneo PM, Dolladille C, Drici MD, Faillie JL, Goldman A, Hauben M, Herdeiro MT, Mahaux O, Manlik K, Montastruc F, Noguchi Y, Norén GN, Noseda R, Onakpoya IJ, Pariente A, Poluzzi E, Salem M, Sartori D, Trinh NTH, Tuccori M, van Hunsel F, van Puijenbroek E, Raschi E, Khouri C. Fusaroli M, et al. Among authors: faillie jl. Drug Saf. 2024 May 7. doi: 10.1007/s40264-024-01421-9. Online ahead of print. Drug Saf. 2024. PMID: 38713346
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration.
Fusaroli M, Salvo F, Begaud B, AlShammari TM, Bate A, Battini V, Brueckner A, Candore G, Carnovale C, Crisafulli S, Cutroneo PM, Dolladille C, Drici MD, Faillie JL, Goldman A, Hauben M, Herdeiro MT, Mahaux O, Manlik K, Montastruc F, Noguchi Y, Norén GN, Noseda R, Onakpoya IJ, Pariente A, Poluzzi E, Salem M, Sartori D, Trinh NTH, Tuccori M, van Hunsel F, van Puijenbroek E, Raschi E, Khouri C. Fusaroli M, et al. Among authors: faillie jl. Drug Saf. 2024 May 7. doi: 10.1007/s40264-024-01423-7. Online ahead of print. Drug Saf. 2024. PMID: 38713347
Drug-induced hyperglycemia and diabetes.
Heurtebize MA, Faillie JL. Heurtebize MA, et al. Among authors: faillie jl. Therapie. 2024 Mar-Apr;79(2):221-238. doi: 10.1016/j.therap.2023.09.010. Epub 2023 Oct 31. Therapie. 2024. PMID: 37985310 Review.
Will the future of pharmacovigilance be more automated?
Salvo F, Micallef J, Lahouegue A, Chouchana L, Létinier L, Faillie JL, Pariente A. Salvo F, et al. Among authors: faillie jl. Expert Opin Drug Saf. 2023 Jul-Dec;22(7):541-548. doi: 10.1080/14740338.2023.2227091. Epub 2023 Jul 12. Expert Opin Drug Saf. 2023. PMID: 37435796 Review.
Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series.
Coustal C, Vanoverschelde J, Quantin X, Lesage C, Michot JM, Lappara A, Ederhy S, Assenat E, Faure M, Issa N, Lambotte O, Puyade M, Dereure O, Tosi D, Rullier P, Serre I, Larcher R, Klouche K, Chanques G, Vernhet-Kovacsik H, Faillie JL, Agullo A, Roubille F, Guilpain P, Maria ATJ. Coustal C, et al. Among authors: faillie jl. J Immunother Cancer. 2023 May;11(5):e004792. doi: 10.1136/jitc-2022-004792. J Immunother Cancer. 2023. PMID: 37258037 Free PMC article.
91 results